Cumulative effect of maternal vascular malperfusion types in the placenta on adverse pregnancy outcomes

Say, 2014, Global causes of maternal death: a WHO systematic analysis, Lancet Global Health, 2, 33, 10.1016/S2214-109X(14)70227-X Hiersch, 2017, Recurrent placenta-mediated Complications in women with three consecutive deliveries, Obstet. Gynecol., 129, 416, 10.1097/AOG.0000000000001890 Brosens, 2011, The "Great Obstetrical Syndromes" are associated with disorders of deep placentation, Am. J. Obstet. Gynecol., 204, 193, 10.1016/j.ajog.2010.08.009 Burton, 2009, Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy, Placenta, 30, 473, 10.1016/j.placenta.2009.02.009 Jauniaux, 2003, Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies, Am. J. Pathol., 162, 115, 10.1016/S0002-9440(10)63803-5 Catov, 2017, Neonatal outcomes following preterm birth classified according to placental features, Am. J. Obstet. Gynecol., 216, 411e1, 10.1016/j.ajog.2016.12.022 Redline, 2015, Classification of placental lesions, Am. J. Obstet. Gynecol., 213, S21, 10.1016/j.ajog.2015.05.056 Khong, 2016, Sampling and definitions of placental lesions: Amsterdam placental Workshop group consensus statement, Arch. Pathol. Lab Med., 140, 698, 10.5858/arpa.2015-0225-CC Audette, 2018, Screening for fetal growth restriction and placental insufficiency, Semin. Fetal Neonatal Med., 23, 119, 10.1016/j.siny.2017.11.004 Sotiriadis, 2019, ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia, Ultrasound Obstet. Gynecol., 53, 7, 10.1002/uog.20105 Wright, 2017, Maternal vascular malperfusion and adverse perinatal outcomes in low-risk nulliparous women, Obstet. Gynecol., 130, 1112, 10.1097/AOG.0000000000002264 Tranquilli, 2014, The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP, Pregnancy Hypertens, 4, 97, 10.1016/j.preghy.2014.02.001 Terwisscha, 2017, Nederlandese Vereniging voor Obstetrie en Gynaecologie-richtlijn Foetale groeisrestrictie (FGR), Richtlijn van de NVOG, 1, 10 Hoftiezer, 2019, From population reference to national standard: new and improved birthweight charts, Am. J. Obstet. Gynecol., 220, 383e1, 10.1016/j.ajog.2018.12.023 Thompson, 2007, Placenta weight percentile curves for singleton deliveries, Bjog, 114, 715, 10.1111/j.1471-0528.2007.01327.x Altemani, 2003, How many paraffin blocks are necessary to detect villitis?, Placenta, 24, 116, 10.1053/plac.2002.0875 Heerema-McKenney, 2018, Distal Villous Hypoplasia, 12 Nikkels, 2019, Distal Villous Hypoplasia, 123 Heider, 2017, Fetal vascular malperfusion, Arch. Pathol. Lab Med., 141, 1484, 10.5858/arpa.2017-0212-RA Treacy, 2013, Delayed villous maturation of the placenta: quantitative assessment in different cohorts, Pediatr. Dev. Pathol., 16, 63, 10.2350/12-06-1218-OA.1 Park, 2014, Fetal, amniotic and maternal inflammatory responses in early stage of ascending intrauterine infection, inflammation restricted to chorio-decidua, in preterm gestation, J. Matern. Fetal Neonatal Med., 27, 98, 10.3109/14767058.2013.806898 Kim, 2015, Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance, Am. J. Obstet. Gynecol., 213, S53, 10.1016/j.ajog.2015.08.041 Sbrana, 2011, Maternal tobacco use is associated with increased markers of oxidative stress in the placenta, Am. J. Obstet. Gynecol., 205, 246, 10.1016/j.ajog.2011.06.023 Ganer Herman, 2016, The effects of maternal smoking on pregnancy outcome and placental histopathology lesions, Reprod. Toxicol., 65, 24, 10.1016/j.reprotox.2016.05.022 Levy, 2018, Can placental histopathology lesions predict recurrence of small for gestational age neonates?, Reprod. Sci., 25, 1485, 10.1177/1933719117749757 Burton, 2014, Optimising sample collection for placental research, Placenta, 35, 9, 10.1016/j.placenta.2013.11.005 Redline, 2021, Interobserver reliability for identifying specific patterns of placental injury ad defined by the Amsterdam classification, College of American Pathologists, 146, 372 Redline, 2004, Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns, Pediatr. Dev. Pathol., 7, 237, 10.1007/s10024-003-8083-2 Bujold, 2014, Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation, Prenat. Diagn., 34, 642, 10.1002/pd.4403 Roberge, 2017, The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis, Am. J. Obstet. Gynecol., 216, 110, 10.1016/j.ajog.2016.09.076 Lees, 2017, Relevance of haemodynamics in treating pre-eclampsia, Curr. Hypertens. Rep., 19, 76, 10.1007/s11906-017-0766-6 Abalos, 2018, Antihypertensive drug therapy for mild to moderate hypertension during pregnancy, Cochrane Database Syst. Rev., 10 Weiner, 2018, Placental histopathological lesions in correlation with neonatal outcome in preeclampsia with and without severe features, Pregnancy Hypertens, 12, 6, 10.1016/j.preghy.2018.02.001 Aviram, 2018, The role of placental malperfusion in the pathogenesis of preeclampsia in dichorionic twin and singleton pregnancies, Placenta, 70, 41, 10.1016/j.placenta.2018.09.002 Kovo, 2015, Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia, Reprod. Sci., 22, 316, 10.1177/1933719114542024 Nelson, 2014, Placental pathology suggesting that preeclampsia is more than one disease, Am. J. Obstet. Gynecol., 210, 66, 10.1016/j.ajog.2013.09.010 Bustamante Helfrich, 2017, Maternal vascular malperfusion of the placental bed associated with hypertensive disorders in the Boston Birth Cohort, Placenta, 52, 106, 10.1016/j.placenta.2017.02.016 Weiner, 2016, The placental component and obstetric outcome in severe preeclampsia with and without HELLP syndrome, Placenta, 47, 99, 10.1016/j.placenta.2016.09.012 Kovo, 2017, The relationship between hypertensive disorders in pregnancy and placental maternal and fetal vascular circulation, J Am Soc Hypertens, 11, 724, 10.1016/j.jash.2017.09.001 Roberts, 2008, The placenta in pre-eclampsia and intrauterine growth restriction, J. Clin. Pathol., 61, 1254, 10.1136/jcp.2008.055236 Chisholm, 2016, Placental and clinical characteristics of term small-for-gestational-age neonates: a case-control study, Pediatr. Dev. Pathol., 19, 37, 10.2350/15-04-1621-OA.1 Parra-Saavedra, 2015, Correlation between histological signs of placental underperfusion and perinatal morbidity in late-onset small-for-gestational-age fetuses, Ultrasound Obstet. Gynecol., 45, 149, 10.1002/uog.13415 Levy, 2019, Pregnancy outcomes in correlation with placental histopathology in subsequent pregnancies complicated by fetal growth restriction, Placenta, 80, 36, 10.1016/j.placenta.2019.04.001 Gluck, 2019, Pregnancy outcome and placental pathology in small for gestational age neonates in relation to the severity of their growth restriction, J. Matern. Fetal Neonatal Med., 32, 1468, 10.1080/14767058.2017.1408070 Herraiz, 2015, Angiogenesis-related biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of placental dysfunction: an Approach for clinical integration, Int. J. Mol. Sci., 16, 19009, 10.3390/ijms160819009 Chau, 2017, Placental growth factor and pre-eclampsia, J. Hum. Hypertens., 31, 782, 10.1038/jhh.2017.61 Korzeniewski, 2016, Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study, Am. J. Obstet. Gynecol., 214, 629e1, 10.1016/j.ajog.2015.11.015